Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to 0.03%.

  • Usana Health Sciences' Return on Invested Capital fell 600.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.07% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, Usana Health Sciences' Return on Invested Capital stood at 0.03%, which was down 600.0% from 0.06% recorded in Q2 2025.
  • Usana Health Sciences' 5-year Return on Invested Capital high stood at 0.31% for Q4 2021, and its period low was 0.03% during Q3 2025.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.12% (2023), whereas its average is 0.14%.
  • Per our database at Business Quant, Usana Health Sciences' Return on Invested Capital surged by 100bps in 2021 and then plummeted by -2000bps in 2022.
  • Over the past 5 years, Usana Health Sciences' Return on Invested Capital (Quarter) stood at 0.31% in 2021, then tumbled by -64bps to 0.11% in 2022, then increased by 6bps to 0.12% in 2023, then crashed by -44bps to 0.07% in 2024, then tumbled by -57bps to 0.03% in 2025.
  • Its Return on Invested Capital was 0.03% in Q3 2025, compared to 0.06% in Q2 2025 and 0.05% in Q1 2025.